Idorsia Ltd (IDIA.S)
18 Jan 2019
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|Non-Executive Chairman of the Board|
|63||Chief Executive Officer, Delegate of the Board, Member of the Executive Board|
|55||Chief Financial Officer, Executive Vice President, Member of the Executive Board|
|62||Executive Vice President, Chief Scientific Officer, Member of the Executive Board|
|62||Executive Vice President, Head of Global Clinical Development, Member of the Executive Board|
- Swiss stocks - Factors to watch on Jan. 7
- BRIEF-Idorsia Starts Multiple-Dose Efficacy And Safety Study With Cenerimod For Treatment Of Systemic Lupus Erythematosus
- Swiss stocks - Factors to watch on Jan. 4
- Swiss stocks - Factors to watch on Dec. 18
- BRIEF-Idorsia's Selatogrel Phase 2 Clinical Studies Meet Their Objective